Johnson & Johnson is putting its stroke care business up for sale as the company aims to reorganize and rebuild its medtech unit, the Financial Times reports.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Genmab upgraded to Neutral from Underperform at Exane BNP Paribas
- M&A News: Novartis Seals $3.1B Deal to Acquire Anthos
- Largest borrow rate increases among liquid names
- Trump Trade: President advocates to close carried interest tax loophole
- White House readying order to fire thousands of federal health workers, WSJ says